How long should you stop Wegovy before trying for a pregnancy?

Why is Wegovy not suitable when you're trying to conceive?

Semaglutide, the medicine in Wegovy, has not been adequately studied in human pregnancy. Animal studies raised concerns about developmental effects at doses relevant to human treatment, which is why the product licence explicitly excludes use in pregnancy, breastfeeding and in women planning a pregnancy. The precautionary position is firm: this is not a case of "probably fine", it is a case of genuine uncertainty where the cautious path is well-established. Wegovy's licensed indications make no provision for continuation once pregnancy is being planned.

The NHS patient information for semaglutide states directly that you should stop the medicine and tell your doctor if you become pregnant or plan to become pregnant. This is consistent with NHS England's guidance on weight-management injections, which advises that GLP-1 medicines should not be used during pregnancy. There is no licensed dose that is considered safe for a developing pregnancy.

It is also worth noting that significant, sustained weight loss can itself affect fertility and cycle regularity, something worth discussing with your GP before and after stopping treatment, particularly if you have conditions such as polycystic ovary syndrome where weight and hormonal balance interact. If you are curious about how long it typically takes to see weight loss on Wegovy, that context can help you plan a realistic treatment timeline before conception becomes the priority.

How long should the gap actually be before you try to conceive?

Semaglutide has a half-life of roughly one week, meaning it takes around five half-lives (approximately five weeks) for the medicine to clear substantially from your system. However, UK clinical guidance goes further than simple pharmacokinetics. Most sources advise a minimum of two months between your last Wegovy dose and attempting conception, and some specialists prefer a longer interval, particularly if you were on the higher maintenance doses.

The two-month figure appears in NHS England's weight-management-injections guidance and aligns with the wash-out periods discussed in the context of GLP-1 medicines more broadly. Think of it this way: you want a genuine buffer, not just pharmacological clearance. If you are considering the higher 7.2mg maintenance dose that was approved by the MHRA in April 2026, discuss the timing explicitly with your prescriber, the clearance principles are the same, but your individual plan may differ.

Your prescriber or GP is the right person to set your personal timeline. They can also help you think through what happens to your weight management during and after the gap, stopping Wegovy without a plan often means some weight returns, and that conversation is worth having well before you stop injections. You can contact our clinical team with questions about your treatment if you are a current patient.

What about contraception while you're still on Wegovy?

This is a question our prescribers hear regularly, and the answer matters practically. The MHRA advises using effective contraception while on GLP-1 medicines. For semaglutide specifically, there is currently no strong evidence that it reduces the effectiveness of the oral contraceptive pill in the way that tirzepatide (Mounjaro) does, NHS guidance notes no equivalent interaction signal for semaglutide. Even so, NHS England recommends discussing your contraceptive method with your prescriber when starting or continuing a GLP-1 medicine.

If you are using oral contraception and planning to come off it in order to try for a pregnancy, factor that timing into your overall plan alongside the Wegovy wash-out. The two timelines overlap and both need thought. A combined conversation with your GP (covering contraception, stopping Wegovy, the wash-out gap, and what weight management looks like during pregnancy) is more useful than handling each piece separately. The NHS England guidance on weight-management injections covers the contraception and conception points clearly and is worth reading before that appointment.

If you are planning ahead and wondering how long Wegovy takes to work in the first place (or thinking about what your treatment journey looks like before the decision to conceive arises) those are reasonable questions to work through with a clinician before you start.

Who should you talk to, and what happens to your weight management in the meantime?

Stop Wegovy with a plan, not a gap. Your GP is usually the right first conversation, particularly if you are also an NHS patient, they can consider your full medical history, any conditions that may be affected by weight changes during pregnancy, and what monitoring you might need. If you are a private patient, your prescriber can advise on stopping safely and on what the transition looks like.

Weight management during pregnancy is handled differently. Calorie restriction and weight-loss medicines are not appropriate once you are pregnant; the focus shifts to adequate nutrition for you and the baby. Some women find that the appetite changes and improved relationship with food that Wegovy helped establish carry over somewhat after stopping, though this varies. There is no good shortcut here: open conversations with a midwife and GP are the foundations once you are pregnant.

If you are thinking about returning to Wegovy after pregnancy and breastfeeding are complete, that is also a valid planning conversation. Wegovy is available privately through a regulated online pharmacy following a fresh clinical assessment, and the consultation process starts from scratch, which is appropriate, since your health picture will have changed. Explore our weight-loss treatments page whenever you are ready, or take a look at how we work if you want to understand our clinical process first. Our prescribers are available to discuss your situation any day of the week once you start a consultation, there is no appointment slot to book, no waiting-room queue, and no script to follow. The 12pm cut-off applies to same-day dispatch once treatment is approved; for a conversation about planning, timing is not the constraint.